ImExHS (ASX:IME) NonCurrent Deferred Revenue: A$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:IME ImExHS Ltd ASX:IME
48 GF Score
Price A$0.31
GF Value A$0.51
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is ImExHS NonCurrent Deferred Revenue?

ImExHS ASX:IME 48 NonCurrent Deferred Revenue is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:IME with a GF Score™ of 48/100 and a GF Value™ of A$0.51 (Possible Value Trap). The stock has 3 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

ImExHS's non-current deferred revenue for the quarter that ended in Dec. 2025 was A$0.00 Mil.

ImExHS NonCurrent Deferred Revenue Related Terms

ImExHS NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for ImExHS's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImExHS NonCurrent Deferred Revenue Chart

ImExHS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ImExHS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:IME
48GF Score
ImExHS Ltd ASX:IME
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of A$0.00 Mil mean?
ImExHS (ASX:IME) has a NonCurrent Deferred Revenue of A$0.00 Mil as of Dec. 2025. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on ImExHS and its competitors.
Is ImExHS's NonCurrent Deferred Revenue too high?
ImExHS's current NonCurrent Deferred Revenue is A$0.00 Mil. Overall, ImExHS has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ImExHS's NonCurrent Deferred Revenue compare to TMO and DHR?
ImExHS's NonCurrent Deferred Revenue of A$0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Medical Diagnostics & Research company?
A good NonCurrent Deferred Revenue depends on the Medical Diagnostics & Research industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on ImExHS and its competitors. ImExHS's current NonCurrent Deferred Revenue is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ImExHS stock overvalued right now?
Based on GuruFocus' analysis, ImExHS (ASX:IME) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.51, compared to a current price of A$0.31 — trading 40.2% below its estimated fair value. The current NonCurrent Deferred Revenue is A$0.00 Mil. ImExHS's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For ImExHS (ASX:IME), the current NonCurrent Deferred Revenue is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ImExHS (ASX:IME) Overvalued in 2026?

Based on GuruFocus' analysis, ImExHS stock appears to be undervalued. The current stock price of A$0.31 is trading 40.2% below its estimated GF Value™ of A$0.51. GuruFocus considers ImExHS to be Possible Value Trap.

Key valuation signals for ASX:IME:

  • NonCurrent Deferred Revenue: A$0.00 Mil
  • GF Value™: A$0.51 vs. price of A$0.31 (40.2% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the ASX:IME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ImExHS Business Description

Address 32 Martin Place, Level 7, Sydney, NSW, AUS, 2020
ImExHS Ltd is a healthcare technology company engaged in the provision of medical imaging software and radiology services. The company develops and delivers enterprise imaging solutions, including radiology information systems and picture archiving and communication systems, as well as provides diagnostic imaging and teleradiology services to healthcare institutions. The company operates through two reportable segments: Software, which focuses on the development and sale of imaging systems and platforms, and Radiology Services, which provides diagnostic and teleradiology services to hospitals and medical facilities. It generates the majority of its revenue from the Radiology segment.
48GF Score

Get the complete analysis for ASX:IME

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.31
Price
A$0.51
GF Value